← Leaderboards
Lyle D Isaacs
University Of Maryland College Pk Campus
$5,399,389
Attributed
$6,532,472
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $710.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,532,472 · 6
By mechanism
R01$4,881,427 · 3
R35$866,810 · 1
R21$784,235 · 2
Top collaborators
- Volker Briken7 shared
Others in their field
Top investigators on “Series”
- Lawrence Corey · Fred Hutchinson Cancer Center$445,660,381
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- David R. Weir · University Of Michigan At Ann Arbor$276,156,779
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$231,733,045
- Dennis R. Burton · Scripps Research Institute$199,946,411
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
Research focus
SeriesIn VivoWaterPharmaceutical PreparationsMolecularMicrocalorimetryBiomaterial CompatibilityDrug KineticsReceptorBindingSolubilityIonsPropertyIn VitroDesignMaximum Tolerated DoseCytotoxicitySafetyElectrostaticsHepatocyteGlycolurilAffinityDrug ContainersEvaluation
Grant awards (25)
Cucurbit[n]uril-Type Molecular Containers$388,740
R35 · FY2025 · GM · contact PI
Macrocyclic Arenes as Sequestrants for Drugs of Abuse$193,488
R21 · FY2025 · DA · contact PI
Cucurbit[n]uril-Type Molecular Containers$478,070
R35 · FY2024 · GM · contact PI
Macrocyclic Arenes as Sequestrants for Drugs of Abuse$232,488
R21 · FY2024 · DA · contact PI
Cucurbituril Type Receptors as Sequestration Agents for Drugs of Abuse$373,955
R01 · FY2022 · GM · contact PI
Cucurbituril Type Receptors as Sequestration Agents for Drugs of Abuse$373,955
R01 · FY2021 · GM · contact PI
Cucurbituril Type Receptors as Sequestration Agents for Drugs of Abuse$373,955
R01 · FY2020 · GM · contact PI
Helium Recovery System for University of Maryland$213,468
R01 · FY2020 · GM · contact PI
Cucurbituril Type Receptors as Sequestration Agents for Drugs of Abuse$446,438
R01 · FY2019 · GM · contact PI
Antibody-Molecular Container Conjugates for Targeted Delivery$159,983
R21 · FY2019 · CA · contact PI
Cucurbituril Type Receptors as Sequestration Agents for Drugs of Abuse$100,000
R01 · FY2019 · GM · contact PI
Antibody-Molecular Container Conjugates for Targeted Delivery$198,276
R21 · FY2018 · CA · contact PI
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery$365,221
R01 · FY2017 · CA · contact PI
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery$367,380
R01 · FY2016 · CA · contact PI
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery$365,471
R01 · FY2015 · CA · contact PI
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery$358,088
R01 · FY2014 · CA · contact PI
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery$451,748
R01 · FY2013 · CA · contact PI
HYDROPHOBIC SELF-ASSEMBLY$65,959
R01 · FY2005 · GM
HYDROPHOBIC SELF-ASSEMBLY$197,224
R01 · FY2004 · GM
HYDROPHOBIC SELF-ASSEMBLY$4,010
R01 · FY2004 · GM
HYDROPHOBIC SELF-ASSEMBLY$193,140
R01 · FY2003 · GM
HYDROPHOBIC SELF-ASSEMBLY$193,140
R01 · FY2002 · GM
HYDROPHOBIC SELF-ASSEMBLY$168,827
R01 · FY2001 · GM
HYDROPHOBIC SELF-ASSEMBLY$236,640
R01 · FY2000 · GM
HYDROPHOBIC SELF-ASSEMBLY$32,808
R01 · FY2000 · GM